Fierce Pharma

APRIL 10, 2023

In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog aliu Mon, 04/10/2023 - 15:53

Doctors 266

Doctors 266

European Pharmaceutical Review

APRIL 10, 2023

The high reliability of matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) systems for microbiological identification offer an alternative to serological-based methods, according to a review by researchers. “New technologies for the accurate and rapid identification of bacteria are essential in various fields of applied microbiology.

Media 111

Media Healthcare Healthcare Pharmaceutical 111

Fierce Pharma

APRIL 10, 2023

New WHO recommendations on COVID vaccines create more revenue uncertainty: analyst kdunleavy Mon, 04/10/2023 - 10:47

253

253

MedCity News

APRIL 10, 2023

The Health Sector Cybersecurity Coordination Center (HC3) recently issued a report letting healthcare organizations know that they are still being heavily targeted by KillNet, a Russian group of cybercriminals. The number of daily attacks KillNet waged against healthcare organizations using Microsoft Azure increased significantly between November 18 and February 17 — from 10-20 attacks per day in November to 40-60 attacks per day in February.

Healthcare 107

Healthcare Healthcare 107

Advertisement

Distribution

Fierce Pharma

APRIL 10, 2023

In legal battle over abortion pill, conflicting rulings leave future access up in the air zbecker Mon, 04/10/2023 - 11:43

210

210

MedCity News

APRIL 10, 2023

A new study from Bessemer Venture Partners analyzed more than 100 venture-backed healthcare companies to determine the best strategies to scale to $100 million in annual recurring revenue. The report laid out a few main lessons health tech companies should know, such as the importance of nurturing relationships with early customers and making sure efficiency metrics are paid close attention.

Healthcare 107

Healthcare Healthcare 107

MedCity News

APRIL 10, 2023

Pear Therapeutics’ Chapter 11 bankruptcy filing follows three corporate restructurings and the inability to secure additional financing to support commercialization of its FDA-cleared prescription digital therapeutics. An auction of Pear’s assets is expected to happen in early May.

Prescription 107

Prescription FDA Biopharma 107

Fierce Pharma

APRIL 10, 2023

As FDA decision draws near, Sobi revamps RSV antibody deal with AstraZeneca, Sanofi aliu Mon, 04/10/2023 - 10:37

FDA 161

FDA 161

Pharmaceutical Technology

APRIL 10, 2023

The Malaysian Ministry of Health (MoH) has reportedly approved additional indication of Astrazeneca ’s Evusheld 100mg/ml solution for injection (Tixagevimab 100mg/ml and Cilgavimab 100mg/ml) for Covid-19 prevention. Health director-general Tan Sri Dr Noor Hisham Abdullah stated that the approval of Evusheld was granted at the 383rd Drug Control Authority (DCA) meeting.

Medicine 105

Medicine Patients Marketing 105

Fierce Pharma

APRIL 10, 2023

Johnson & Johnson's $8.

213

213

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

APRIL 10, 2023

The share of traditional Medicare enrollees who bought Medicare Supplement coverage rose to 41% in 2021, compared to 35% in 2017, according to a report from America’s Health Insurance Plans. Medicare Supplement enrollees are three times less likely to have issues paying medical bills than those who only have traditional Medicare.

Insurance 105

Insurance Medical 105

Pharmaceutical Technology

APRIL 10, 2023

Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. Aviceda’s HALOS (high-affinity ligands of sigelcs) nanotechnology platform leverages glycobiology to modulate the innate immune system to develop advanced breakthrough therapeutics, focusing on immuno-oncology.

Medicine 103

Medicine Medical 103

Impetus Digital

APRIL 10, 2023

Our client reached out to Impetus to help establish a virtual patient panel with the aim to gather insights on their unmet needs, the most important attributes of treatment , and the impact of treatment on their disease burden and quality of life. In addition, they were looking for patient feedback on their recent clinical trial results, future clinical trial designs, and communications plan.

Patients 97

Patients 97

MedCity News

APRIL 10, 2023

The FDA has asked for more information about cardiac complications reported last year in a Phase 1 study for the Molecular Templates cancer drug, MT-0169. The partial clinical hold comes as the biotech works through a corporate restructuring as well as second Nasdaq de-listing notice.

FDA 96

FDA Biopharma Pharma 96

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Impetus Digital

APRIL 10, 2023

With Earth Week 2023 just around the corner, we thought it was time to officially introduce the award-winning team working behind the scenes to organize our annual Earth Week celebrations and many other sustainability initiatives ! Along with diversity, equity & inclusion (DEI) , sustainability is one of Impetus Digital’s key focus areas. We’re so proud of how far we’ve come since starting our journey in 2020.

Education 96

Education Media Marketing Pharma 96

MedCity News

APRIL 10, 2023

Greater collaboration among healthcare providers, medical device manufacturers, and lawmakers and regulators will lead to predictability and consistency in cybersecurity management. Together, we can make even greater strides toward patient safety and a more secure and sustainable healthcare system.

Manufacturing 95

Manufacturing Medical Healthcare Provider Safety 95

PharmExec

APRIL 10, 2023

Agency hopes to attract more seasoned expertise in manufacturing; also looking to add field inspectors.

Manufacturing 123

Manufacturing FDA 123

MedCity News

APRIL 10, 2023

A new white paper from Intelligent Medical Objects highlights how the aviation, military, law enforcement industries and other sectors confronted data challenges to improve data collection and what the healthcare industry can learn from these examples.

Healthcare 95

Healthcare Healthcare Medical 95

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

MedReps

APRIL 10, 2023

There’s always that moment during an interview where you find yourself without an answer to an important question. Whether the interviewer is asking about statistics (how much of a certain product have you sold in the past year?) or something more general (can you discuss a time when you had to do something that did not suit your strengths?) doesn’t matter.

Medical sales 81

Medical sales Sales Medical Medical sales reps 81

MedCity News

APRIL 10, 2023

Zocdoc, a healthcare marketplace, is adding Federally Qualified Health Centers (FQHCs) to its platform. Patients are now able to find and book appointments with FQHCs working with Zocdoc on the company’s website or app, and can filter based on factors like specialty and location.

Healthcare 94

Healthcare Healthcare Patients 94

Medgadget

APRIL 10, 2023

Researchers at Rice University have developed a new type of microparticle for drug delivery, made from a polymer called PLGA that has already been extensively explored as a component in drug delivery systems. However, what makes these new particles different is the method of loading and sealing them, which appears to give them highly tunable release characteristics and may even allow the researchers to create particles that provide multiple doses of a drug, or continuous dosing, over the space o

Medicine 81

Medicine Patients Management Medical 81

PharmaVoice

APRIL 10, 2023

Intarcia looked poised to break into a lucrative diabetes implant market but has been dogged by safety issues — now Vivani thinks it’s found a way to succeed.

Safety 59

Safety Marketing 59

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Scott’s Directories

APRIL 10, 2023

Are you a marketer looking to sell your services to doctors in New Brunswick? If so, a list of doctors may just be the tool you need to reach potential clients. Not only does a list give you access to information about the medical professionals in the area, but it also presents a host of other benefits that can help grow your client base. In this blog post, we’ll explore some of the top reasons why marketing teams should utilize a list of doctors in New Brunswick to sell their services.

Doctors 52

Doctors Marketing Physicians Networking 52

Spotio

APRIL 10, 2023

According to LinkedIn, the average sales professional spends less than 30% of their time selling. Why? Simple: They’re completely bogged down by non-selling activities. Fortunately, there are a few things you can do to remedy the situation. First and foremost, you can learn how to measure sales productivity. Doing so will help you identify where your reps waste the most time and substitute those activities for more effective ones.

Sales 52

Sales Leads Sales Strategy Prospecting 52

Pharma Marketing Network

APRIL 10, 2023

Bill Clinton: My fellow Americans, I stand here today to argue in favor of universal government-funded healthcare. The United States is the wealthiest country in the world, yet we have the highest number of uninsured citizens. This is not only morally wrong, but it also puts a strain on our economy. When citizens are uninsured, they are less likely to seek preventative care and more likely to delay treatment until their condition becomes severe.

Government 52

Government Healthcare Healthcare Competition 52

Pharmaceutical Technology

APRIL 10, 2023

The Australian Government’s Department of Health and Aged Care has announced the availability of new medicines for graft versus host disease (GVHD), chronic rhinosinusitis, and oesophageal cancer. To be provided under the Pharmaceutical Benefits Scheme (PBS), the new and updated medicines include Jakavi (ruxolitinib), Nucala (mepolizumab), and Opdivo (nivolumab).

Medicine 52

Medicine Government Patients Pharmaceutical 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmExec

APRIL 10, 2023

Bankrupt Clovis Oncology offloads assets, including ovarian cancer drug Rubraca, to Swiss firm Pharma& Schweiz for over $70 million.

Pharma 52

Pharma 52

Pharmaceutical Technology

APRIL 10, 2023

India-based pharmaceutical company Cipla has entered into a perpetual licence agreement with Swiss drugmaker Novartis Pharma for the diabetes drug Galvus and its combination brands. Under the deal, Cipla will be responsible for the manufacturing and marketing of Galvus and its combination brands from 1 January 2026. Galvus brand products are mainly used in the treatment of patients with type 2 diabetes.

Manufacturing 52

Manufacturing Medicine Pharma Sales 52

PharmaTech

APRIL 10, 2023

Will court challenges to FDA’s oversight authority open the door for multiple lawsuits to block agency decisions on all sides?

FDA 52

FDA 52

Pharmaceutical Commerce

APRIL 10, 2023

Demands for services in this sector have increased since last year’s Q1 Scientific acquisition, CDMO says.

52

52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management